Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Translocations chromosome 21:

Search results

Items: 1 to 20 of 1614

1.

Long range haplotyping of paired-homologous chromosomes by single-chromosome sequencing of a single cell.

Luo D, Zhang M, Liu T, Cao W, Guo J, Mao C, Li Y, Wang J, Huang W, Lu D, Zhang S, Li Z, He J.

Sci Rep. 2018 Jan 26;8(1):1640. doi: 10.1038/s41598-018-20069-x.

2.

Down Syndrome - Genetics and Cardiogenetics.

Plaiasu V.

Maedica (Buchar). 2017 Sep;12(3):208-213.

3.

Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?

Tsuchiya KD, Davis B, Gardner RA.

Cancer Genet. 2017 Dec;218-219:10-14. doi: 10.1016/j.cancergen.2017.08.005. Epub 2017 Aug 31.

PMID:
29153092
4.

MPO-negative inclusions and Auer rod-like structures in a case of acute myeloid leukemia with t(8;21).

Harankhedkar S, Gupta R.

Blood. 2017 Oct 19;130(16):1869. doi: 10.1182/blood-2017-05-780817. No abstract available.

PMID:
29051153
5.

B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy.

Zhang X, Rastogi P, Shah B, Zhang L.

Oncotarget. 2017 Jul 15;8(39):66728-66741. doi: 10.18632/oncotarget.19271. eCollection 2017 Sep 12. Review.

6.

Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation?

Foley N, Van Ziffle J, Yu J, Qi Z, Grenert JP, Yeh I, Bastian B, Kogan S, Mannis GN.

Cancer Genet. 2017 Oct;216-217:74-78. doi: 10.1016/j.cancergen.2017.07.002. Epub 2017 Jul 31.

PMID:
29025598
7.

Children with low-risk acute lymphoblastic leukemia are at highest risk of second cancers.

Nielsen SN, Eriksson F, Rosthoej S, Andersen MK, Forestier E, Hasle H, Hjalgrim LL, Aasberg A, Abrahamsson J, Heyman M, Jónsson ÓG, Pruunsild K, Vaitkeviciené GE, Vettenranta K, Schmiegelow K.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26518. Epub 2017 May 13.

PMID:
28500740
8.

Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia.

Ragon BK, Daver N, Garcia-Manero G, Ravandi F, Cortes J, Kadia T, Oran B, Ohanian M, Ferrajoli A, Pemmaraju N, Kantarjian HM, Borthakur G.

Am J Hematol. 2017 Sep;92(9):845-850. doi: 10.1002/ajh.24782. Epub 2017 Jun 9.

PMID:
28494506
9.

Opposite chromosome constitutions due to a familial translocation t(1;21)(q43;q22) in 2 cousins with development delay and congenital anomalies: A case report.

Aleksiūnienė B, Matulevičiūtė R, Matulevičienė A, Burnytė B, Krasovskaja N, Ambrozaitytė L, Mikštienė V, Dirsė V, Utkus A, Kučinskas V.

Medicine (Baltimore). 2017 Apr;96(16):e6521. doi: 10.1097/MD.0000000000006521.

10.

Assessing the miRNA sponge potential of RUNX1T1 in t(8;21) acute myeloid leukemia.

Junge A, Zandi R, Havgaard JH, Gorodkin J, Cowland JB.

Gene. 2017 Jun 5;615:35-40. doi: 10.1016/j.gene.2017.03.015. Epub 2017 Mar 16.

PMID:
28322996
11.

Acute myeloid leukemia with t(3;21)(q13;q22), a novel simple variant of the 21q22/RUNX1 translocation.

Tsuruoka Y, Sakai H, Uchida A, Uemura Y, Sato K, Yokoi S, Nishio Y, Matsunawa M, Suzuki Y, Isobe Y, Kato M, Tomita N, Inoue Y, Miura I.

Rinsho Ketsueki. 2017;58(1):3-8. doi: 10.11406/rinketsu.58.3. Japanese.

PMID:
28190862
12.

ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.

Yamato G, Shiba N, Yoshida K, Shiraishi Y, Hara Y, Ohki K, Okubo J, Okuno H, Chiba K, Tanaka H, Kinoshita A, Moritake H, Kiyokawa N, Tomizawa D, Park MJ, Sotomatsu M, Taga T, Adachi S, Tawa A, Horibe K, Arakawa H, Miyano S, Ogawa S, Hayashi Y.

Genes Chromosomes Cancer. 2017 May;56(5):382-393. doi: 10.1002/gcc.22443. Epub 2017 Feb 14.

PMID:
28063196
13.

Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.

Alm SJ, Engvall C, Asp J, Palmqvist L, Abrahamsson J, Fogelstrand L.

Int J Lab Hematol. 2017 Apr;39(2):121-128. doi: 10.1111/ijlh.12593. Epub 2016 Dec 22.

PMID:
28004528
14.

The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.

Mandoli A, Singh AA, Prange KHM, Tijchon E, Oerlemans M, Dirks R, Ter Huurne M, Wierenga ATJ, Janssen-Megens EM, Berentsen K, Sharifi N, Kim B, Matarese F, Nguyen LN, Hubner NC, Rao NA, van den Akker E, Altucci L, Vellenga E, Stunnenberg HG, Martens JHA.

Cell Rep. 2016 Nov 15;17(8):2087-2100. doi: 10.1016/j.celrep.2016.08.082.

15.

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.

Eisfeld AK, Kohlschmidt J, Schwind S, Nicolet D, Blachly JS, Orwick S, Shah C, Bainazar M, Kroll KW, Walker CJ, Carroll AJ, Powell BL, Stone RM, Kolitz JE, Baer MR, de la Chapelle A, Mrózek K, Byrd JC, Bloomfield CD.

Leukemia. 2017 Jun;31(6):1278-1285. doi: 10.1038/leu.2016.332. Epub 2016 Nov 15.

16.

Clinical and molecular cytogenetic studies in ten patients with hematological malignancies characterized by t(20;21)(q11;q11) resulted from del(20q).

Wu C, Zhang J, Bai S, Yao J, Qiu H, Xue Y, Chen S, Wu Y, Shen J, Pan J.

Cancer Genet. 2016 Oct;209(10):456-462. doi: 10.1016/j.cancergen.2016.09.006. Epub 2016 Sep 19.

PMID:
27810074
17.

Molecular combing: A new tool in diagnosing leukemia.

Ittel A, Zattara H, Chaix C, Michel G, Levy N.

Cancer Biomark. 2016;17(4):405-409. doi: 10.3233/CBM-160656.

PMID:
27802191
18.

RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report.

Panagopoulos I, Torkildsen S, Gorunova L, Ulvmoen A, Tierens A, Zeller B, Heim S.

Oncol Rep. 2016 Nov;36(5):2481-2488. doi: 10.3892/or.2016.5119. Epub 2016 Sep 22.

19.

Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t(8; 21) acute myeloid leukemia: A prospective, randomized study.

Li R, Hu X, Wang L, Cheng H, Lv S, Zhang W, Wang J, Yang J, Song X.

Am J Hematol. 2017 Jan;92(1):12-17. doi: 10.1002/ajh.24569. Epub 2016 Oct 21.

20.

AML1-ETO promotes SIRT1 expression to enhance leukemogenesis of t(8;21) acute myeloid leukemia.

Zhou L, Wang Q, Chen X, Fu L, Zhang X, Wang L, Deng A, Li D, Liu J, Lv N, Wang L, Li Y, Liu D, Yu L, Dou L.

Exp Hematol. 2017 Feb;46:62-69. doi: 10.1016/j.exphem.2016.09.013. Epub 2016 Oct 8.

PMID:
27725192

Supplemental Content

Loading ...
Support Center